The emerging therapy of the medication represents a major breakthrough in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and GIP – leading to improved glucose management and potential weight loss. Experts are studying its long-term advantages and part in the overal… Read More